BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33969605)

  • 21. Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
    Belgiovine C; Frapolli R; Bonezzi K; Chiodi I; Favero F; Mello-Grand M; Dei Tos AP; Giulotto E; Taraboletti G; D'Incalci M; Mondello C
    PLoS One; 2010 Nov; 5(11):e14154. PubMed ID: 21209796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
    Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells.
    Gadea G; Sanz-Moreno V; Self A; Godi A; Marshall CJ
    Curr Biol; 2008 Oct; 18(19):1456-65. PubMed ID: 18835169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt5a signaling induced phosphorylation increases APT1 activity and promotes melanoma metastatic behavior.
    Sadeghi RS; Kulej K; Kathayat RS; Garcia BA; Dickinson BC; Brady DC; Witze ES
    Elife; 2018 Apr; 7():. PubMed ID: 29648538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma.
    Liu Q; Zhu H; Tiruthani K; Shen L; Chen F; Gao K; Zhang X; Hou L; Wang D; Liu R; Huang L
    ACS Nano; 2018 Feb; 12(2):1250-1261. PubMed ID: 29370526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A.
    Tang Y; Cao K; Wang Q; Chen J; Liu R; Wang S; Zhou J; Xie H
    Oncol Rep; 2016 May; 35(5):2907-15. PubMed ID: 26934938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway.
    MacMillan CD; Leong HS; Dales DW; Robertson AE; Lewis JD; Chambers AF; Tuck AB
    Sci Rep; 2014 Sep; 4():6315. PubMed ID: 25204426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions.
    Klein RM; Aplin AE
    Cancer Res; 2009 Mar; 69(6):2224-33. PubMed ID: 19244113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.
    Margheri F; Luciani C; Taddei ML; Giannoni E; Laurenzana A; Biagioni A; Chillà A; Chiarugi P; Fibbi G; Del Rosso M
    Oncotarget; 2014 Mar; 5(6):1538-53. PubMed ID: 24681666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
    Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
    Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Canonical WNT5A Signaling Through RYK Contributes to Aggressive Phenotype of the Rheumatoid Fibroblast-Like Synoviocytes.
    Rodriguez-Trillo A; Mosquera N; Pena C; Rivas-Tobío F; Mera-Varela A; Gonzalez A; Conde C
    Front Immunol; 2020; 11():555245. PubMed ID: 33178184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Podoplanin drives dedifferentiation and amoeboid invasion of melanoma.
    de Winde CM; George SL; Crosas-Molist E; Hari-Gupta Y; Arp AB; Benjamin AC; Millward LJ; Makris S; Carver A; Imperatore V; Martínez VG; Sanz-Moreno V; Acton SE
    iScience; 2021 Sep; 24(9):102976. PubMed ID: 34485858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation.
    Dehghani-Ghobadi Z; Sheikh Hasani S; Arefian E; Hossein G
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NG2-mediated Rho activation promotes amoeboid invasiveness of cancer cells.
    Paňková D; Jobe N; Kratochvílová M; Buccione R; Brábek J; Rösel D
    Eur J Cell Biol; 2012; 91(11-12):969-77. PubMed ID: 22699001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
    Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration.
    Zhu Y; Tian Y; Du J; Hu Z; Yang L; Liu J; Gu L
    PLoS One; 2012; 7(5):e37823. PubMed ID: 22655072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
    Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
    Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual VEGF/PDGF knockdown suppresses vasculogenic mimicry formation in choroidal melanoma cells via the Wnt5a/β-catenin/AKT signaling pathway.
    Yuan Y; Geng B; Xu X; Zhao H; Bai J; Dou Z; Jia S; Yu X; Luo W
    Acta Histochem; 2022 Jan; 124(1):151842. PubMed ID: 34995928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt5a/ROR1 activates DAAM1 and promotes the migration in osteosarcoma cells.
    Dai B; Shen Y; Yan T; Zhang A
    Oncol Rep; 2020 Feb; 43(2):601-608. PubMed ID: 31894282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
    Yamazaki D; Kurisu S; Takenawa T
    Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.